Children’s Hospital Los Angeles paused Sarepta’s Elevidys gene therapy after FDA flagged safety issues, including deaths in ...

Company CEO Doug Ingram said the pause was necessary for Sarepta to maintain a "productive and positive working relationship" ...

The agency also revoked Sarepta's platform technology designation for AAVrh74 Friday and issued a safety communication saying ...

The layoffs followed a March announcement by Health Secretary Robert F. Kennedy Jr., who called for a major department overhaul.

Neuralink has successfully completed two brain implant surgeries in a single day. Sharing the achievement, Elon Musk ...

Collaborating on Food Safety Culture” resumes Sept. 3, following a nine-month hiatus, with the webinar “How to Turn a Problem into an Opportunity.” ...

Sarepta says it will continue to ship Elevidys despite FDA requests that it stop shipments of the Duchenne muscular dystrophy ...

Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, published results of a proteomics ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...